Antares Pharma's (ATRS) CFO Resigns

August 11, 2016 7:15 AM EDT
Get Alerts ATRS Hot Sheet
Trade ATRS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Antares Pharma (NASDAQ: ATRS) disclosed in an SEC filing:

On August 5, 2016, Antares Pharma, Inc. (the “Company”) received a written notice of resignation from James E. Fickenscher, the Company’s Senior Vice President and Chief Financial Officer. Mr. Fickenscher’s resignation will become effective September 4, 2016. Mr. Fickenscher is resigning from the Company to pursue other interests, and his resignation is not a result of any dispute or disagreement with the Company. The Company has initiated a search for a new Chief Financial Officer.

Upon Mr. Fickenscher’s departure, Keith Muckenhirn, age 53, the Company’s Vice President, Finance and Corporate Controller since 2011, will assume the roles of interim Chief Financial Officer, principal accounting officer and principal financial officer while the Company completes its search process for a permanent Chief Financial Officer. Mr. Muckenhirn joined the Company in 2001 as Controller and has more than 30 years of experience in accounting and financial reporting.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Management Comments

Add Your Comment